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and Antonio Queiros, O.D., Ph.D.
Purpose: Higher myopic refractive errors are associated with serious ocular
complications that can put visual function at risk. There is respective
interest in slowing and if possible stopping myopia progression before it
reaches a level associated with increased risk of secondary pathology. The
purpose of this report was to review our understanding of the rationale(s)
and success of contact lenses (CLs) used to reduce myopia progression.
Methods: A review commenced by searching the PubMed database. The
inclusion criteria stipulated publications of clinical trials evaluating the
efﬁcacy of CLs in regulating myopia progression based on the primary
endpoint of changes in axial length measurements and published in peer-
reviewed journals. Other publications from conference proceedings or patents
were exceptionally considered when no peer-review articles were available.
Results: The mechanisms that presently support myopia regulation with
CLs are based on the change of relative peripheral defocus and changing the
foveal image quality signal to potentially interfere with the accommodative
system. Ten clinical trials addressing myopia regulation with CLs were
reviewed, including corneal refractive therapy (orthokeratology), peripheral
gradient lenses, and bifocal (dual-focus) and multifocal lenses.
Conclusions: CLs were reported to be well accepted, consistent, and safe
methods to address myopia regulation in children. Corneal refractive therapy
(orthokeratology) is so far the method with the largest demonstrated efﬁcacy in
myopia regulation across different ethnic groups. However, factors such as
patient convenience, the degree of initial myopia, and non-CL treatments may
also be considered. The combination of different strategies (i.e., central
defocus, peripheral defocus, spectral ﬁlters, pharmaceutical delivery, and
active lens-borne illumination) in a single device will present further testable
hypotheses exploring how different mechanisms can reinforce or compete
with each other to improve or reduce myopia regulation with CLs.
Key Words: Myopia progression—Contact lens—Peripheral defocus—
Accommodation—Spectral ﬁlter—Refractive error regulation—Refractive
therapy—Orthokeratology.
(Eye & Contact Lens 2014;00: 1–11)
T here is increasing interest in actively interfering with theprogression of myopia rather than simply compensating for
the refractive deﬁcit associated with the condition. Refractive ther-
apeutic intervention addresses myopia not only as a refractive
anomaly that can be optically compensated but also a condition
that can be treated (or at least managed), as Rubin and Milder
suggested in 1976.1 However, those authors still advocated for
conservative (compensatory) treatments based on the lack of evi-
dence to support other treatments portending to address myopia
progression.
An interesting report from Kelly et al.2 in 1975 compared the
myopia progression in several cohorts of patients using spectacles
alone (control), spectacles plus atropine, contact lenses (CLs)
alone, and CLs plus atropine. They concluded that CLs alone were
the least effective method to regulate myopia progression. The ﬁrst
reports on the potential beneﬁcial role of CLs as treatments to
reduce myopia progression were published in the early 70s. How-
ever, little information is available from studies by German re-
searchers Küster3 and Volckmar.4 Later reports in the 80s by
Kerns,5 Drobec,6 Andreo,7 and Goldschmidt8 reported the potential
of CL to reduce myopia progression. Although pharmacological
and spectacle-based optical treatments were the object of extensive
review works,9–12 no updated information is available in the CL
ﬁeld, despite the numerous advances in the last half of that
decade.13
In the 90s, Singaporean researchers Heng and Khoo published
a review article with a suggestive title, “Can contact lenses control
the progression of myopia?” in which they discussed the potential
role of strategies such as regular wearing of rigid gas-permeable
lenses and orthokeratology lenses to regulate myopia progression.
The authors concluded that more research in the Asian eye was
necessary, as most of the evidence reported early in the 70s had
been with Caucasian eyes.14 Since then, a great deal of new scien-
tiﬁc knowledge and clinical evidence has been presented and will
be discussed in this review. The question today may be rephrased
as “Which contact lenses are more effective to regulate the pro-
gression of myopia?” Thus, the aim of this review is to present
a summary of the evidence published in peer-reviewed journals
related to CL strategies to regulate myopia progression. Other treat-
ments not involving CL wear are out of the scope of this report.
The authors of this report choose the terms “refractive therapy”
and “refractive error regulation” as the most accurate terms for the
future therapeutic management of refractive errors. The animal
studies to date support the ability to inﬂuence scleral growth in
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either direction; hence, the terminology will apply in the event
there is interest or need beyond the present discussion of myopia
to regulate hyperopia and astigmatism toward emmetropization.
The refractive therapy efforts described here are only a part of
the overall research in regulating myopia. The following discus-
sion is limited to CL refractive therapy in contrast to pharma-
ceutical refractive therapy. Heretofore, the term myopia control
has been used by some. The authors prefer the term regulate
instead of control consistent with other medical therapeutic
interventions.
Socioeconomic Burden and Risks of
Myopia Progression
The increase in the prevalence of myopia and the complications
associated with the condition have a large socioeconomic impact.
Costs associated with myopia can be classiﬁed as direct costs,
related to spending on eyeglasses, ophthalmic lenses, CLs, and
health care ofﬁce visits, or indirect costs, associated with surgical
interventions and treatment of retinal detachment, glaucoma, or
lack of productivity derived from visual impairment or blind-
ness.15,16 A study conducted in Singapore with 301 subjects
between the ages of 12 and 17 years revealed that the mean annual
direct cost of myopia for each subject in Singapore dollars was
$221.76313.7 (US $1486$209.1). Based on age-speciﬁc preva-
lence of myopia, the authors estimated that costs of $37.5 million
would be required to correct myopia for only Singaporean teen-
agers.17 In 2006, Vitale et al.18 conducted a study for the National
Health and Nutrition Examination Survey (NHANES) in the
United States and estimated the annual direct cost of correcting
myopia to be between $3.9 and $7.2 billion.
Ocular diseases such as cataract, glaucoma, maculopathy, and
retinal detachment are often associated with high myopia increas-
ing the risk of blindness. These sequelae establish myopia as
a major public health problem in some countries in East Asia and
in certain ethnic groups such as the Chinese.19–23 The deﬁnition of
pathological myopia is not clear in the literature, and a single
deﬁnition is complicated because patients with lower myopia also
exhibit pathological ocular ﬁndings.24 However, it is accepted that
the higher the myopia, the greater is the risk of pathological
changes. In the Blue Mountains Eye Study, the risk for myopic
maculopathy increased from ·2.2 for myopia below 3.00 diopter
(D) to ·41 for myopia between 25.00 and 27.00 D and to ·350
for myopia over 29.00 D.25 The risk for retinal detachment shifts
from ·5 to ·10 for myopia under 23.00 D to myopia over 23.00
D, according to a Japanese study.26 Table 1 exempliﬁes the average
myopia progression per year in different studies for periods ranging
from 4 to 8 years. Most of these studies evaluated the general
population; of course, the rates of progression are expected to be
faster in the becoming myopic or myopic population.
This risk differential highlights the relevance of treatments
directed to keeping myopia at lower levels. Therapeutic interven-
tion is even more relevant considering the evidence that points to
higher prevalence of myopia in the younger populations, even in
western countries, as has been reported in the U.S. NHANES.33,34
Contact Lenses and Pathways to Reduce
Myopia Progression
It is very important for clinicians to be aware of the rationale that
supports the application of optical treatments to regulate myopic
progression. We will discuss the role of peripheral myopic defocus,
the role of near add power to compensate for the higher accom-
modative demand, the role of accommodative lag, and very brieﬂy
will comment on the recently proposed role of modulation of the
activity of different visual pathways by means of spectral ﬁlters.
Relative Peripheral Defocus
Results from several animal species including young chickens35
and monkeys36 have demonstrated that their eyes are capable of
responding to myopic or hyperopic defocus by altering their pos-
terior chamber shape. Asymmetrical ocular elongation results when
defocus is only imposed in one half of the retina or when different
sign defocus is imposed in both hemiﬁelds.37 Troilo and Wallman
were able to demonstrate that the supposed visually guided eye
growth mechanism in chickens tends to recognize defocus and
adjust axial growth according to its signal even with a sectioned
optic nerve. The authors concluded that the mechanism behind the
defocus sign recognition and eye growth modulation must be
located within the eye and be somehow independent from central
neural system, while brain activity must be maintained for emme-
tropia to succeed.38
When infant rhesus monkeys were raised with central opening
diffusers that deprived the animal’s peripheral vision allowing only
clear foveal vision, an accelerated axial elongation resulted.39 The
monkeys were then submitted to another experience where their
TABLE 1. Summary of Studies Evaluating the Annual Progression of Myopia Derived With Cycloplegic Refraction and/or Axial Length Elongation in
Children Aged 6 to 12 Years From Different Ethnicities
Author (Year) Sample (n, Eyes) Ethnicity Age Methods D/year
Elongation
(mm/year)
Pointer
(2001)27
60 (41) Caucasian 7–13 Static dry retinoscopy+Sx 20.09 D/yr (stable
from 11 to 13)
NR
Xiang et al.
(2012)28
607 Chinese (twins) 7–15 Cycloplegic autorefraction 20.7 D/yr 0.21 mm/yr
Fan et al.
(2004)29
255 Chinese 2–6 Cycloplegic autorefraction/
ultrasound biometry
20.24 D/yr 0.34 mm/yr
Zhao et al.
(2002)30
4662 myopes Chinese 5–13 Cycloplegic autorefraction 20.18 D/yr (20.37) NR
Anderson
et al.
(2011)31
114 myopes 8 Asians, 19 blacks, 29 whites, 51 Hispanics, and
7 individuals of mixed ethnicity
7–13 Noncycloplegic
autorefraction
20.23 D/yr NR
Shih et al.
201032
Aggregate from
different studies
Urban Chinese population 7–12 Different methods Boys: 20.20; girls:
20.27
NR
NR, not reported.
José M. González-Méijome et al. Eye & Contact Lens  Volume 00, Number 00, Month 2014
2 Eye & Contact Lens  Volume 00, Number 00, Month 2014
central vision was deprived by foveal ablation and only clear
peripheral vision was allowed. The authors concluded that foveal
vision is not essential for the emmetropization to occur in primates
and that peripheral retina visual experience may be responsible for
the regulation of ocular growth.
A recent study reported by Liu and Wildsoet concluded that
myopic peripheral defocus with refractive-corrected central vision
(concentric multifocal CLs) results in an inhibitory effect on axial
eye growth in young chickens, but the contrary effect occurred
when myopic defocus was restricted only to central vision with
a focused peripheral area.40
Whether by design or default, most of the currently available
treatments for myopia regulation with CL can be viewed as owing
their success to their propensity to change the relative peripheral
defocus. Several patents have been issued for this purpose.
Commercially available and investigational devices falling in this
category will be discussed further in the Discussion section.
Accommodative Lag and Phoria at Near
Different studies have linked myopia onset and myopia pro-
gression with increased levels of near-vision work,41 and a link to
the activity of the accommodative system has been established.42,43
Eyes after the onset of myopia are observed to have greater accom-
modative lag (under-accommodation for a given target distance)
compared with emmetropic eyes.44 The same study suggests that
higher accommodative lag seems to be a consequence instead of
a cause of myopia. Considering the higher lag, myopic eyes are
exposed to hyperopic defocus and respective poor image qual-
ity45,46 during near-work, and these optical effects may have a role
in the myopia progression mechanism. Weizhong et al.47 could not
demonstrate a higher myopia progression in myopic eyes having
higher accommodative lag. This contradiction leads to some con-
troversy regarding the role of accommodative lag alone in myopia
progression.
The use of bifocals or progressive addition ophthalmic lenses for
slowing the progression of myopia has been reported to result in
small therapeutic regulation of myopia. Myopia showed 0.15 to 0.50
D slower progression in the treatment groups when compared with
control groups over a period of 1.5 to 3 years.48–50 Despite the
positive effect of the intervention with bifocal and progressive addi-
tion lenses, the low annual regulation may not be clinically relevant
for the general population of patients with myopia.
Other studies showed a greater effectiveness with bifocal and
progressive addition ophthalmic lenses in children with esophoria
and high accommodative lag.51 Moreover, some authors have re-
ported that high myopia is related to higher esophoria.52 The link
between esophoria and accommodative lag might provide a work-
ing hypothesis based on the relationship between the accommoda-
tive and convergence systems.53 A hypothesis in patients with
esophoria suggests that the accommodative lag is higher to prevent
the increase of the esophoria at near. Thus, providing a near add
will warrant that the visual effects in the form of hyperopic defocus
at near associated with a higher lag will be minimized.
Concentric bifocal CLs might also provide myopia regulation by
imposing some degree of peripheral myopic defocus. This has been
postulated by Smith54 and suggests a synergistic effect by interfer-
ing simultaneously with the foveal vision partially compensating
the negative effects of accommodative lag and simultaneously
inducing peripheral myopic defocus. However, our evaluations
using an open-ﬁeld autorefractometer failed to detect any signiﬁ-
cant effect on peripheral refraction or relative peripheral defocus by
concentric annular multifocal CLs.55 The autorefractometer meas-
ures covered an area of 2.3 mm in diameter. The measurement zone
might be too large to detect the power differences between 6 con-
centric rings of alternating near and distance power. Aberrometric
evaluation for smaller pupil sizes may bring more detailed infor-
mation on the sign of the local peripheral defocus with concentric
bifocal CLs. Even so, measurement of such lenses may not be
accurate with Hartmann-Shack sensors because of the overlapping
and duplication of the microarray spots formed by light passing
through the distance and near power rings.
Instead of solely compensating for accommodative lag using
a positive add at near, another alternative is to improve the
accommodative response in the myopic eye. Allen et al.56 re-
ported a reduction in accommodative lag of myopic eyes by
ﬁtting soft CLs to induce 20.1 mm of fourth-order spherical
aberration at a pupil diameter of 5.0 mm. For the average eye
with positive spherical aberration,57 this intervention will
push the best image focus backwards and the eye will need
to accommodate more efﬁciently to bring it forward to the
retinal plane.
Contact lens devices falling in this kind of intervention include
the use of refractive and diffractive bifocal CLs, near-center
multifocal CLs, and single vision lenses with induced negative
spherical aberration to improve accommodative function56 without
the purpose of multifocal vision. CLs with negative spherical aber-
ration will induce relative peripheral hyperopic defocus.58 This is in
opposition to the desired myopic peripheral defocus previously
described. Both mechanisms within the same device could interact
in an antagonistic way. Commercially available and investigational
devices falling in this category will be discussed further in the
Discussion section.
METHODS
A search was performed in PubMed (www.pubmed.com) using
the following combination of keywords “myopia progression con-
tact lens” by June 2014; this was the combination that produced the
most sensitive and speciﬁc outcome. The primary outcome of inter-
est in this search was to ﬁnd the peer-reviewed publications ad-
dressing the potential effect of CLs on myopia progression, with
particular interest in clinical trials conducted in the ﬁeld. Selection
criteria were original articles or case reports published in peer-
reviewed journals from 2004 to 2014 reporting clinical and bio-
metric data of eye growth and myopia progression with CLs; no
conference abstracts nor review articles were considered. A total of
107 citations were retrieved. Of them, 49 were related to generic
topics and not directly related to the use of CL in myopia research,
19 were review articles, 9 were investigating the effect of CL on
peripheral refraction, and 4 were related to animal studies. Of the
remaining 26 articles reporting clinical trials, 9 were related to
single vision contact lenses (SVCL), 8 to orthokeratology or cor-
neal refractive therapy, 2 to non-orthokeratology gas-permeable
CLs, 3 to bifocal soft CLs, 1 to multifocal dominant design CL,
and 1 to peripheral gradient CLs. There was one case report related
to the use of orthokeratology and one related to bifocal CLs. For
the purpose of this review, the results of the last eight studies with
orthokeratology/corneal refractive therapy, six studies describing
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the use of other CLs, one study reporting the results of a dominant
design multifocal CL for presbyopia, and two studies on the effect
of SVCL have been tabulated and subjective to more detailed
analysis and discussion.
RESULTS
The main characteristics of the CL designed with the primary
purpose of regulating myopia progression and their reported
effectiveness are discussed here. Other CLs that have been reported
in isolated case reports or in systematic clinical trials with their
respective effectiveness as myopia regulation treatments are
included. Table 2 presents a summarized overview of the main
outcomes of the clinical case reports and clinical trials. Considering
the strong body of literature arising in the recent years for ortho-
keratology/corneal refractive therapy treatments, Table 3 addresses
speciﬁcally the outcomes of these studies. A graphical overview of
these interventions is shown in Figure 1 for an approximate sim-
ulated pupil size of 6 mm.
DISCUSSION
Refractive Bifocal and Multifocal CLs
Goldschmidt,8 in a review article published in 1990, described
the results of a Danish study conducted in the 80s, which was
reported to show evidence of the beneﬁcial effect of bifocal CLs
on myopia progression. To our knowledge, this is one of the ﬁrst
results reported in the peer-reviewed literature (although indirectly)
on the potential effect of CL in preventing myopia progression.
Bifocal and Dual-focus Contact Lenses
Bifocal lenses used with the purpose of reduction of myopia
progression included ACUVUE Bifocal lens (Johnson & Johnson,
Jacksonville, FL) made of etaﬁlcon A (ionic, 58% water content)
with a total diameter of 14.0 mm and a base curve radius of 8.5
mm. The optical design of the lens comprises a central distance
zone with a diameter of 2 mm surrounded by a 0.6 width near
addition ring, a 0.6 mm width distance ring, a 0.35 near addition
ring, and a ﬁfth 1.45-mm wide distance ring (approximate design
shown in Fig. 1C).
The use of bifocal CLs to prevent myopia progression with
modern CLs was initiated by Aller and Wildsoet who reported on the
case of two identical twin sisters in a cross-over clinical ﬁtting during
2 years. They found that bifocal CLs were able to reduce the ocular
growth in the twin sisters alternatively ﬁtted with ACUVUE
Bifocal.59 Furthermore, the authors reported in 2006 on a 1-year
clinical trial testing the efﬁcacy of ACUVUE Bifocal CL in myopic
endophoric patients. They reported a 71% reduction in refractive
change as measured with cycloplegic autorefraction and a 79%
reduction in axial length with the bifocal CL.60
The only human randomized controlled clinical trial with this
category of lenses was conducted by Anstice and Phillips66 with
refractive bifocal (dual-focus) CLs in the Dual-focus Inhibition of
Myopia Evaluation in New Zealand study. Dual-focus CLs consist
of a hydrophilic soft CL made of hioxiﬁlcon A, nonionic 49%
water content material (Benz Research and Development, Sarasota,
FL), with a total diameter of 14.2 mm and a base curve of 8.5 mm.
The optical design consists of a series of concentric areas starting
with a 3.36-mm central distance area, surrounding by a 0.71-mm
width treatment zone (near zone), a 0.99 distance zone ring, and
a 0.78 with second treatment zone. A graphical representation of
the lens design is shown in Figure 1G over a 6-mm diameter. In
this study, either eye of 40 young children between 11 and 14 years
of age was randomly ﬁtted with a dual-focus lens or with a single
vision lens and replaced bimonthly.
After a period of 10 months with the ﬁrst prescription, the
treatments were switched between right and left eyes. In this clinical
trial, right eye lenses were blue-tinted to avoid confusion. At the end
of the study, data from the 2 parts of the study (up to a total of 20
months) were combined to obtain the progression effect during dual-
focus and single vision lens wearing. The spherical equivalent
refraction increased by 20.4460.33 D in the dual-focus group and
20.6960.38 D in the single vision lens group (P,0.001). Axial
length increased by 0.1160.09 mm for the eyes during the dual-
focus lens wearing and 0.2260.10 mm during the single vision lens
wearing (P,0.001).
Another recent approach to regulate myopia progression with
CL is represented by the defocus incorporated soft contact lens
(DISC). This is a refractive concentric bifocal soft CL comprising
10 to 12 rings of alternating power over the optic zone. A graphical
representation of the lens design is shown in Figure 1H. In the lens
description presented by the authors in the animal studies conducted
with pigmented guinea pigs, the authors describe the lenses as Fresnel
lenses designed to minimize spherical aberration.77 The 2-year clinical
trial in humans was completed by 65 children wearing the DISC
lenses bilaterally and 63 children wearing single vision CLs.67 The
clinical group using the DISC lenses showed a 31% lower axial
elongation compared with the SVCL group over the 2-year period.
Apparently, the retention effect was positively correlated with the
number of hours of lens wear, varying from 25% for the subjects
wearing the lenses for shorter periods during the day to 60% for those
wearing the lenses 8 or more hours. However, the authors only pro-
vided this analysis in terms of spherical equivalent refraction rather
than axial elongation, so blur adaptation in those wearing the lenses
for longer periods might confound this analysis. Additionally, the
authors do not report the average age of subjects in each group of
wearing time, which might also be a confounding factor, as older
children tend to progress at a slower rate than younger children.
Although this fact might not be relevant, some recent develop-
ments supporting the use of blue-tinted lenses to provide myopic
regulation effect might bring a possible additional source of
variability in myopia regulation effect, although this observation
is merely speculative.76
Multifocal Center-Distance Contact Lenses
Center-distance multifocal CLs are used for presbyopia correc-
tion. Their optical design has been proposed as a viable way to
induce myopic peripheral defocus,79 which may be inhibitory for
axial elongation similar to the refractive effect created with corneal
refractive therapy.
Center-distance multifocal CLs used in myopia progression
studies were Proclear (CooperVision, Pleasanton, CA) dominant
“D” design lens made of omaﬁlcon A (nonionic, 62% water con-
tent), with an overall diameter of 14.2 mm and a base curve radius
of 8.6 mm. The optical design consists of a spherical central zone
of 2.3 mm in diameter dedicated to distance vision, surrounded by
an annular aspheric zone of 5.0 mm (1.35-mm width) of increasing
addition power and a spherical annular zone of 8.5 mm (1.50 mm
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width) reaching the maximum add power. This design is presently
available also in the Bioﬁnity multifocal (comﬁlcon A, 48% water
content silicone hydrogel material).
The amount of relative peripheral refractive error is correlated with
the add power chosen from +1 to +3 D.78,79 Figure 1D represents the
in vitro power proﬁle for a 22.00 D distance powered with +2.00 D
add Proclear D lens; Figure 1E,F represent the on-eye corneal topog-
raphy power map over a plano lens at distance with add power of +3
and +4 D. Walline and McVey reported on the potential beneﬁt of
using Proclear multifocal dominant “D” design as a method to reg-
ulate myopia progression in children. The Bifocal Lens Inhibition of
Myopia Progression study was a 2-year study comparing the pro-
gression of myopia between children wearing single vision CLs and
age-matched children wearing multifocal dominant design lenses.
Two-year outcome reported was a regulation effect in axial length
growth of 29% in the children who used Proclear D (add power
+2.00 D) when compared with the cohort wearing conventional
single vision CLs. The authors claimed a 50% regulation effect in
the progression of refractive error. A statistically signiﬁcant, though
weak correlation existed between baseline myopia and axial length
regulation.80
Peripheral Gradient Lenses
Similar to center-distance multifocal lenses, custom rigid gas
permeable and soft CLs can be designed to compensate for central
myopic errors, and at the same time, they impose peripheral
positive defocus.81 A special soft CL with these features was used
in a clinical trial to assess its effectiveness in myopia regulation.61
The treatment CLs made of a silicone hydrogel lens material (8.6-mm
base curve, 14.2-mm diameter, lotraﬁlcon B; CIBA Vision, Duluth,
GA) had a clear central zone that corrected for the eye’s central
refractive error (1.5-mm semichord and 1.5 mm within a relative plus
of +0.25 D). Outside the central zone, the refracting power of the lens
increased progressively in relative positive power to reach a relative
positive power of +1.00 D at 2 mm semichord and +2.00 D at a semi-
chord of 4.5 mm. Approximate design is shown in Figure 1I.
Sankaridurg et al. performed a randomized and controlled
clinical trial in China with a cohort of 43 Chinese children aged
from 7 to 14 years, with baseline spherical refractive error ranging
between 20.75 and 23.50 D and 21.00 D or less of astigmatism,
and who were treated with the special design CLs for a period of 12
months. The control group consisted of 39 Chinese children with
similar baseline ocular characteristics and age range who were
treated with single vision spectacle lenses during the same period.
At the end of the 12 months, the eyes treated with the special
contact lens showed a 33% slower axial elongation compared to
the control group treated with single vision lenses. Although the
regulation effect of myopia progression is still below the expected,
it demonstrates the effectiveness of this category of CL for the
regulation of myopia.
TABLE 2. Summary of Studies Evaluating the Myopia Regulation Effect With Single Vision, Multifocal, Dual-Focus, Gradient Power
Author (Year) Ethnicity (Age) Study Design (Durationa) Test Group (n Eyes) (Rx Range)
Control Group (n Eyes)
(Rx Range)
Aller and Wildsoet (2008)59 Caucasian Case report ACUVUE Bifocal (n=2) SV SCL (n=2)
Aller and Wildsoet (2006)60 Various (8–18) Randomized (12 months) ACUVUE Bifocal (n=38) SV SCL (n=40)
Sankaridurg (2011)61 Chinese (7–14) Parallel, controlled,
randomized (6 months)
Peripheral gradient (45)
(22.2460.79)
Spectacles (40) (21.9960.62)
Parallel, controlled,
randomized (12 months)
Peripheral gradient (43)
(20.75, 23.50)
Spectacles (39) (20.75, 23.50)
Walline and McVey 201062 NR (10–11) 24 months Multifocal CL (n=14)
(–2.3161.05)
SV SCL (14) (–2.2260.97)
Horner et al. (1999)63 NR (11–14) 3 years SV SCL (n=62) (23.0160.22) Spectacles (68) (23.1060.21)
Walline et al. (2008)64 47.1% white, 21.5% black,
21.5% Hispanic, 6.6%
Asian or Pacific Islander
(8–11)
3 years SV SCL (237) (22.3860.98) Spectacles (247) (22.4361.10)
Marsh-Tootle et al. (2009)65 Ethnically diverse (5–6) 2 years Spectacles (106) (24.3261.40) SV SCL (77) (24.2561.52)
Antice and Phillips (2010)66 Various (11–14) Cross-over, controlled,
randomized (20 months)
Dual-focus (n=35)
(21.25, 24.00)
SV SCL (n=35) (21.25, 24.00)
Lam et al. (2014)67 Chinese (8–13) Controlled, randomized,
(24 months)
DISC (n=65) (22.9061.05) S (n=63) (22.8061.03)
Author (Year) Refraction Method Biometric Method
Dioptric Progression in
Test Group vs. Control
(Regulation Effect, %)
Axial Growth in Test Group vs.
Control (Regulation Effect, %)
Aller and Wildsoet (2008)59 Noncycloplegic refraction IOLMaster 0.00 vs. 21.25 (100%) NR (at baseline)
Aller and Wildsoet (2006)60 Cycloplegic autorefraction IOLMaster 20.22 vs. 20.78 (71.8%) 0.05 vs. 0.24; 0.19 mm (79.2%)
Sankaridurg (2011)61 Cycloplegic open-field
autorefraction
20.28 vs. 20.57 (50.9%) 0.09 vs. 0.26; 0.17 mm (65.4%)
20.54 vs. 20.84 (37.5%) 0.24 vs. 0.39; 0.15 mm (38.5%)
Walline and McVey 201062 Cycloplegic open-field
autorefraction
A-scan ultrasonography 20.55 vs. 21.10 (50.0%) 0.32 vs. 0.47; 0.15 mm (31.9%)
Horner et al. (1999)63 Noncycloplegic subjective
examination
NR 14.7% NR
Walline et al. (2008)64 Cycloplegic autorefraction A-scan ultrasonography 21.30 vs. 21.12 (216.1%) 0.62 vs. 0.59; 20.03 mm (25.1%)
Marsh-Tootle et al. (2009)65 Cycloplegic autorefraction A-scan ultrasonography 47.1% 11.1
Antice and Phillips (2010)66 Cycloplegic autorefraction IOLMaster 20.17 vs. 20.38 (55.3%) 0.03 vs. 0.15; 0.15 mm (80.0%)
Lam et al. (2014)67 Cycloplegic autorefraction IOLMaster 20.59 vs. 20.80 (26%) 0.25 vs. 0.36 (31%)
SV SCL, single vision soft contact lenses; NR, not reported; DISC, defocus incorporated soft contact lenses.
aReport from interim results before study completion.
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TABLE 3. Summary of Studies Evaluating Myopia Regulation Effect With Corneal Refractive Therapy (Orthokeratology)
Author (Year) Cheung et al. (2004)68 Cho et al. (2005)69 Walline et al. (2009)70 Kakita et al. (2011)71
Santodomingo-Rubido
et al. (2012)72
Test group (n eyes,
M/F) (average SER)
Ortho-k (n=1 eye, male)
(22.50-0.50·170)
Ortho-k (n=34, 16/19)
(22.2761.09)
CRT (n=28, 16/19)a Ortho-k (n=28, 21/21)
(22.5561.82)
Ortho-k (n=31, 15/16)
(22.35)
Ethnicity Chinese Chinese Caucasian Japanese Caucasian
Age range 13 7–12 8–11 8–16 6–12
Mean age (years) — 9.6 10.5 12.0 9.7
Range SER, D 22.50 20.25 to 24.00 20.75 to 24.00 20.50 to 210.00 20.75 to 24.00
Max. cylinder, D 20.50 22.00 21.00 21.50 21.00
Refraction baseline Noncycloplegic refraction Noncycloplegic
refraction
Cycloplegic autorefraction Noncycloplegic
autorefraction
Cycloplegic autorefraction
Duration of study,
years
3 2 2 2 2
Randomization Case report Nonrandomized Historic data Nonrandomized Nonrandomized
Control group
(n eyes, M/F)
(average Rx)
Emmetrope (n=1 eye)
(20.25-0.75·168)
SVSL (n=34, 16/19)
(22.5560.98)
SVSL SVSL (n=50, 22/28)
(22.5961.66)
SVSL (n=30, 15/15)
(22.53)
Refraction Noncycloplegic refraction Cycloplegic refraction,
retinoscopy
Cycloplegic autorefraction Noncycloplegic
autorefraction
Cycloplegic autorefraction
Biometry (outcome
measures)
US A-Scan (VCD, AL) US A-scan 5500,
(VCD, AL)
US A-scan (ACD, LT,
VCD, AL)
PCI (AL) PCI (AL)
Dioptric regulation
(D) effect, %
+3.25 vs. 20.75, 2118%
vs. 150%
+2.0961.34 vs.
21.2060.61,
292% vs. 47%
a +1.8761.34 vs.
21.2461.71,
273% vs. 48%
+1.86 vs. 21.27, 280% vs.
50%
Increase AL treated
vs. control, mm
0.13 vs. 0.34 0.2960.27 vs. 0.546
0.27
0.2560.72 vs. 0.5760.74 0.3960.27 vs.
0.6160.24
0.47 vs. 0.69
Mean growth
regulation effect
per year (%)
20.11 mm (62%) 20.12 mm (46%) 20.16 mm (56%) 20.11 mm (36%) 20.11 mm (32%)
Contact lens WAVE lens Boston XO/Paragon Paragon CRT Emerald Menicon Z Night
Material NR HDS Paragon HDS 100 Boston XO Tisilfocon A
Dkc NR 100·10211 100·10211 100·10211 163·10211
Central thickness 0.22 mm NR NR NR NR
Overall diameter 10.6 mm NR NR NR NR
Optic zone diameter 6.0 mm NR NR NR NR
Author (Year) Hiraoka et al. (2012)73 Chen et al. (2012)74 Cho et al. (2012)75 Charm and Cho (2012)76
Test group (n eyes, M/F)
(average SER)
Ortho-k (n=22, 10/12)
(21.8960.82)
Ortho-k (n=25, —/—)
(22.6460.82)
Ortho-k (n=37, 19/18)
(22.1660.77)
Ortho-k (n=12, —/—)
(26.38)
Ethnicity Japanese Chinese Chinese Chinese
Age range 8–12 9–14 7–10 8–11
Mean age (years) 10.0 11.2 9.0 10.0
Range SER, D 20.50 to 25.00 21.00 to 24.50 20.50 to 24.50 25.00 to 28.30
Max. cylinder, D 21.50 21.50 21.50 21.50
Refraction baseline Noncycloplegic refraction Noncycloplegic refraction Noncycloplegic refraction Cycloplegic refraction
Duration of study, years 5 2 2 2
Randomization Nonrandomized Nonrandomized Randomized Randomized, single-
masked
Control group (n eyes, M/F)
(average Rx)
SVSL (n=21, 8/13)
(21.8361.06)
SVSL (n=22, NR/NR)
(22.4060.86)
SVSL (n=41, 22/19)
(22.3660.86)
SVSL (n=16, —/—) 2(6.00)
Refraction Noncycloplegic autorefraction NR Cycloplegic refraction Cycloplegic autorefraction
Biometry (outcome measures) PCI (AL) PCI (AL) PCI (AL) AL
Dioptric regulation (D) effect,
%
+1.19 vs. 23.20,
263% vs. 175%
NR NR 20.13 vs. 21.00, 0.87 D
(87.0%)
Increase AL treated vs. control,
mm
0.9960.47 vs. 1.4160.68 0.55 vs. 0.50b 0.3660.24 vs. 0.6360.26 0.19 vs. 0.51
Mean growth regulation effect
per year (%)
20.13 mm, 37% (2 years);
20.08 mm, 30% (5 years)
+0.05 mm, 210%b 20.14 mm (43%) NR
Contact lens Emerald Hiline Menicon Z Night Procornea
Material Boston XO Boston XO Tisilfocon A Boston XO
Dkc 100·10211 100·10211 163·10211 100·10211
Central thickness 0.22 mm NR NR 0.22 mm
Overall diameter 10.6 mm 10.6–10.8 mm NR 10.5 mm
Optic zone diameter NR 6.0 mm NR 6.0 mm
Positive values of dioptric regulation effect and negative values of axial growth regulation effect mean a lower ocular elongation in the
orthokeratology group.
aRefractive error and corneal curvature are temporarily altered by orthokeratology, so they are not compared in this investigation.
bAuthors do not report the increment in AL for the whole sample in the orthokeratology group or SVL group, so an average of the data
presented by the authors for their different subgroups is displayed in the table.
cBarrer (cm2/s) (mL$O2/mL·mm Hg).
AL, axial length; Average Rx, average Rx at baseline; NR, not reported; PCI: partial coherence interferometry (IOLMaster, Carl Zeiss, Dublin,
CA); SVCL, single vision contact lenses; SVSL, single vision spectacle lenses; US, ultrasound; VCD, vitreous chamber depth.
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Single Vision Contact Lenses
Conventional single vision soft CLs are largely used to correct
refractive errors. It has been described recently that undercorrec-
tion, full correction, and overcorrection with single vision soft CL
causes hyperopic shifts in the peripheral visual ﬁeld.82 In another
study, Shen et al.,83 using commercially available spherical CLs,
reported the ability to decrease the amount of relative peripheral
hyperopia. This seems to be more effective in high myopia (man-
ifest spherical equivalent=28.3162.10 D), where central refractive
correction with spherical CLs can result in signiﬁcant absolute
myopic peripheral defocus.85
Other studies performed to evaluate myopia progression reported
that single vision CLs do not produce an effect on the change of
refractive development in a test group when compared with a control
group wearing spectacle lenses.63,64 When children switched from
spectacle lenses to CLs, Marsh-Tootle et al.65 found a signiﬁcant
but clinically irrelevant increase in myopia. Fulk et al.85 reported
an increase in the amount of myopia three times faster in children
who switched to single vision CLs than those who remained in
spectacles (mean difference, 20.74 D; P,0.001). Nevertheless, no
differences were observed in the vitreous chamber depth, and the
refractive change between both groups was related with the change
FIG. 1. Representation of the optical
design of different contact lenses with
potential to retain myopia progression over
the 6 mm of the pupil and graphs repre-
senting the approximate power profile
over the central 8 mm: (A) corneal refrac-
tive therapy for an axial myopia of 23.5 D;
(B) corneal refractive therapy for axial
myopia of +1.5 D; (C) bifocal annular
design; (D) power profile of a multifocal
center-distance soft contact lens as mea-
sured in vitro; (E) and (F) power profile of
a multifocal center-distance soft contact
lens on-eye with +3.00 and +4.00 D of
addition for near, respectively, as measured
with a corneal topographer; (G) dual-focus
as described by Anstice and Phillips66; (H)
defocus incorporated special contact lens
(DISC)67; and (I) peripheral gradient design
as described by Sankaridurg et al.61 Note:
Drawings might not be a true representa-
tion of the lens design; some lens designs
might be different for different patients
depending on their pupil size, refractive
error, or other clinical parameters. Graphs
do not represent the actual profiles re-
flected in the maps. Red areas represent
maximum positive power, whereas blue or
green areas represent distance refractive
correction (plano for the purpose of this
comparison). All graphs are drawn to rep-
resent a maximum power addition of 3 D
over a base of plano power except for A
(+3.50), B (+1.50), F (+4.00), and G
(+2.00).
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veriﬁed in corneal curvature (mean difference, 0.189 D, P=0.007),
probably related with molding effects or slight edema.
An additional form of single vision intervention in myopia
progression has been tested in the context of the Cambridge Anti-
myopia Study (CAMS). Allen et al.67 used CLs to induce negative
spherical aberration to improve the accommodative function and
reduce the accommodation lag in myopic eyes. The CAMS evaluated
the role of accommodative visual therapy and negative spherical aber-
ration CL, alone or combined in myopia progression, in adolescents
and young adults from 14 to 22 years of age in a 2-year randomized
controlled clinical trial. The results of the CAMS clinical trial were
recently published and concluded that there was no effect of improving
accommodative function either through vision training alone, negative
spherical aberration lenses alone, or the combination of both on myo-
pia progression. It is necessary to consider that these CLs will probably
induce relative peripheral hyperopia as a result of their aspheric design
as has been observed in multifocal CLs using center-near designs.58
Thus, there is a possibility that the potential beneﬁt of improving the
accommodative function could be somewhat counterbalanced by the
negative effect of induced hyperopic peripheral defocus.
Corneal Refractive Therapy and Orthokeratology
In the last decade, several clinical studies evaluated the effect of
overnight corneal reshaping for the temporary correction of myopia
in the regulation of myopia progression. Cheung et al. reported the
case of an 11-year-old child treated with orthokeratology in one
eye with full undercorrection in the contralateral eye. This case
showed a reduction in myopia progression of 62% compared with
the contralateral eye not wearing an orthokeratology lens.68
Between 2005 and 2012, the results of 6 different clinical trials
have been reported in 7 peer-reviewed publications. All of them
agreed that treatment with overnight corneal reshaping lenses
demonstrated regulation of myopia progression by 30% to 50% in
children of different ethnicities aged 8 to 12 years.
Lenses used in these studies were tetracurve and pentacurve
reverse geometry lenses and proximity control lenses made of
paﬂufocon D (Paragon HDS 100), hexafocon A (Boston XO), and
tisilfocon A (Menicon Z). A graphical representation of the power
proﬁle of the cornea over a 6-mm pupil diameter after overnight
corneal reshaping for a moderate (23.5 D) and low (21.5 D)
myopic correction is presented in Figure 1A and 1B, respectively.
Four of the most recently published studies report on East Asian
populations,69,71 one report results from the United States,70 and the
second reports on Caucasian patients living in Spain.72 A summary
of these and other studies and their characteristics and outcomes
are reported in Table 3. Only studies including vitreous chamber or
axial length measurement as a primary outcome were included in
this analysis. With the exception of the U.S. study, all studies
included a control population of spectacle wearers. The U.S. study
included a control population of soft CL wearers. The follow-up
time was 2 years with the exception of the Japanese study pre-
sented by Hiraoka et al.73 Hiraoka et al. reported on the 5-year
outcomes showing an average myopia regulation effect of 30%
over the 5 years compared with the 37% regulation effect presented
previously by Kakita et al.71 in the same population. This might
suggest that the therapeutic regulation effect of orthokeratology
might decline over time. The apparent decline might also be related
to a slower myopia progression in the control population, as
the children became older. Santodomingo-Rubido et al. in 2012
reported a regulation effect of 32% over 2 years in children aged
6 to 12 years.
More recently, the results of the only randomized clinical trial
(Retardation of Myopia in Orthokeratology study) conducted in
Hong Kong conﬁrmed the results of previous studies with an
average axial growth regulation effect of 43% at a consistent rate of
20.14 mm per year in children wearing orthokeratology lenses
compared with spectacle wearers who experienced an average
growth of 0.63 mm per year.75
Considering the consolidated evidence of the role of corneal
refractive therapy on regulating myopia progression, there is
a growing interest in evaluating the potential factors associated
with a higher or lower efﬁcacy of the treatment. Baseline myopia
was considered as a potential candidate to predict the efﬁcacy of
the treatment, considering the linear relationship between baseline
myopia and the relative peripheral refractive error induced by the
corneal refractive therapy treatment. However, only Cho et al. in
the LORIC study have been able to demonstrate a moderate and
statistically signiﬁcant direct correlation between the amount of
baseline myopia and the effect on myopia regulation.69 More
recently, Chen et al. demonstrated that pupil size might have a sig-
niﬁcant impact on myopia regulation. In their study, larger pupils
were associated with a greater efﬁcacy of the treatment, whereas
smaller pupil size was related to no regulation effect74 as Figure
1A,B illustrate. Previous studies using orthokeratology for myopia
regulation did not report on the potential effect of pupil size on the
degree of myopia regulation.
Despite the apparent susceptibility of East Asian ethnic groups
to suffer myopia, corneal refractive therapy has shown to be
effective in all ethnic groups including Asian, Caucasian, and
African ethnic groups.
A closer observation to information displayed in Table 3 shows
that the lenses used in different studies are made of different ma-
terials and using different designs. Despite the differences in over-
all lens diameter and optical zone diameter, all studies are
consistently showing similar myopia regulation of approximately
40%. Considering the recently observed relationship between pupil
size and the myopia regulation effect, one might expect that the
smaller treatment zones might be associated to higher myopia reg-
ulation. However, Kang et al. have recently reported that the
peripheral refraction pattern was not signiﬁcantly different between
lenses with different treatment zones.86
It is presently accepted that the mechanism to explain lower
myopia progression with corneal refractive therapy is the relative
peripheral myopization optical effect resulting from ﬂattening the
central cornea and steepening the midperipheral cornea.87–90 The
effect of the treatment on foveal vision as a result of the higher order
aberrations induced91 may also have a therapeutic effect and is
a worthwhile outcome to observe in future studies to evaluate if there
is a synergistic effect between the manipulation of the peripheral
refraction and the induction of bifocality/multifocality in the foveal
region. The authors are aware of current developments in this ﬁeld,
but no current report is available in the peer-review literature so far.
The report of the effect of pupil size on treatment efﬁcacy and
the apparent role of the retinal area and location of the defocus
raise issues for the role of the lens registration with regard to the
center of the pupil or visual axis. Displacement of a multifocal CL
or a corneal refractive therapy treatment induces on-axis coma
while also shifting the peripheral defocus and generating an
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asymmetric peripheral defocus circumferentially. Future studies
might beneﬁt from the inclusion of measurement of lens registra-
tion and evaluation of its impact on treatment efﬁcacy.
Safety of Contact Lenses for Myopia Regulation
Refractive therapy in the form of CLs for the regulation of
myopia is targeted to be prescribed for children and adolescents.
Safety must be a primary goal. In the context of the present review,
two different safety issues or risks are raised, as the two modalities
of CL wearing raise their respective safety concerns. The ﬁrst one
is the safety of overnight wearing of corneal refractive therapy
lenses, and the second is the safety of daily wearing of soft CLs
with multifocal optics.
The safety of overnight corneal refractive therapy has been
questioned, particularly after the cases of microbial keratitis
presented mainly in Asian children in the early years of the past
decade.92 Most of these reports showed positive cultures for micro-
organisms that were potentially related to poor compliance. Indeed,
the rate of reporting of adverse events in orthokeratology patients
has decreased for the last 5 to 7 years, whereas the number of
children ﬁtted in this modality has increased as a consequence of
the higher evidence of efﬁcacy as a myopia regulation modality.
Despite a signiﬁcant part of contact lens–related corneal infections
in children was related with corneal refractive therapy in a recent
study in Hong Kong, those cases responded well to treatment and
recovered without visual loss.93 Recently, Bullimore et al. reported
the rates of microbial keratitis in orthokeratology patients. A trend
for higher indices of adverse events in children compared with
adults was reported.94 The reported risk was signiﬁcantly lower
than the numbers reported risk for overnight wear of soft CLs in
extended or continuous modalities.95 Overall, corneal refractive
therapy is now considered an effective and safe alternative to cor-
rect and regulate myopia progression.96
Other less severe complications of overnight corneal refractive
therapy are important to understand. Early work by Walline et al. in
the context of the COOKI study showed that children wearing
orthokeratology lenses for 6 months did not reported serious
complications. The most frequent ﬁnding reported was central
superﬁcial punctate staining.97 These ﬁndings have been conﬁrmed
by most of the subsequent longitudinal 2 to 5-year studies with ortho-
keratology presented in the next section. Santodomingo-Rubido
et al.,98 in the context of the Myopia Control with Orthokeratology
in Spain study, reported the rate of adverse events and discontinuations
in the orthokeratology clinical arm compared with the spectacles con-
trol arm. They reported 16 adverse events in children wearing ortho-
keratology, including 11 related with the CL (5 corneal erosions, 2
clinically signiﬁcant corneal staining, 2 papillary conjunctivitis, 1 CL
peripheral ulcer, and 1 dimple veiling). Most of the events occurred
between the 6 and 12 months of treatment over the 2 years of the
study, and none of them compromised visual function.
Studies were reviewed of daily wearing of soft CLs by children
and adolescents. Jones-Jordan et al. in the context of the Adolescent
and Child Health Initiative to Encourage Vision Empowerment
(ACHIEVE) study reported that children are able to safely wear
CLs.99 Studies of the safety of daily disposable CLs are useful to
estimate the risks.66,100,101 Unfortunately, none of the studies re-
ported, including soft CLs designed speciﬁcally for myopia regula-
tion, had adequate statistical power for a safety analysis or provided
information regarding the complications or adverse events.61,66,80
At present, there is no evidence that younger CL wearers are at
a higher risk than adults for the occurrence of adverse events or
even minor complications. Chalmers et al. have recently shown
that age is a signiﬁcant risk factor for inﬁltrative events in young
CL wearers, this risk was the lowest for the age range from 8 to 15
years,102 which is consistent with the age range for CL prescribing
for myopia regulation as shown by the age proﬁles in the studies
presented in this review.
CONCLUSIONS
Regulating myopia progression might provide substantial bene-
ﬁts in lowering the risks of several sight-threatening complications
linked to moderate and high myopia. Contact lenses are convenient
optical devices for the purpose of regulating myopia progression
for several reasons: (1) they maintain near alignment with the
optics of the eye, providing a more consistent effect than
spectacle plane ophthalmic lenses; (2) they are well accepted
esthetically, which is particularly important with children and
teens; and (3) they have acceptable levels of safety96,97 in terms
of side effects.
Presently, different strategies are available that differ in their
principle of action and also in their wearing modality. We are faced
with the possibility and probability that the ethical/professional
responsibility is to therapeutically intervene to regulate the rate of
progression of the disease instead of following the traditional
standard of prescribing a spectacle or CL refractive corrective.
From the clinical point of view, there are several conclusions
that can be derived. First, CLs demonstrate greater efﬁcacy over
spectacles for eyes with higher myopia because of their inherent
ability to reduce the peripheral hyperopic defocus induced by
spectacle lenses.83 Second, corneal refractive therapy (orthokera-
tology) is at present the modality with the largest volume of accu-
mulated evidence relating to the efﬁcacy to regulate myopia
progression in children.69,70,72,73 To date, the effect of treatment
interruption and the presence or absence of subsequent myopia
progression has not been adequately evaluated. Third, soft multi-
focal CLs are available and design reﬁnements will become avail-
able to regulate myopia progression, and multifocal CLs have been
reported to have promising preliminary results.61,66 Long-term ran-
domized controlled clinical trials with multifocal CLs with meth-
ods including pupil size measures, vitreous chamber depth
increase, and peripheral refraction are needed. This could eventu-
ally elucidate the potential cumulative effect over time and the
effect of treatment interruption.
In summary, CLs are ideal platforms for incorporating peripheral
defocus, imposed foveal defocus, and speciﬁc aberration structures,
independently or in combination with each other. The combination
of several different utilities might potentially reinforce the
effectiveness of the currently available approaches.
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